Liposomal Bupivacaine Injection Suppliers & Bulk Manufacturers

Available Forms: Liposomal injectable solution

Available Strengths: 133 mg/20 mL (6.6 mg/mL)

Reference Brands: EXPAREL

Category: Liposomal Drug Delivery

Liposomal Bupivacaine Injection is available in Liposomal injectable solution and strengths such as 133 mg/20 mL (6.6 mg/mL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Liposomal Bupivacaine Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Liposomal Bupivacaine Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Liposomal bupivacaine (EXPAREL) is regulated in the EU and US with dossiers demonstrating safety, efficacy, and manufacturing quality aligned with GMP standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity with MDR standards for regional anesthesia. These formulations undergo validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective extended-release local anesthetic solutions, supporting postoperative pain management worldwide and improving patient outcomes.